Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Good News Ventures is a Toronto-based venture capital firm that specializes in pre-seed and seed-stage investments in high-growth technology startups. While the firm is a generalist investor, it maintains a significant portfolio in the health technology and digital health sectors, backing companies that innovate in healthcare delivery, pharmacy management, and accessibility. The firm provides early-stage entrepreneurs with financial capital, strategic mentorship, and access to a global network of industry experts to facilitate scaling. Good News Ventures typically targets startups in North America that demonstrate strong technical defensibility and scalability. Their investment approach is characterized by being among the first institutional investors in a company's lifecycle, supporting founders from the earliest stages of development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Good News Ventures.